{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:20:37Z","timestamp":1783488037932,"version":"3.55.0"},"reference-count":448,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018870","name":"Swedish Heart and Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018870","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.isci.2024.111153","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T19:19:21Z","timestamp":1728674361000},"page":"111153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Fatty acid abnormalities in cystic fibrosis\u2013the missing link for a cure?"],"prefix":"10.1016","volume":"27","author":[{"given":"S\u0142awomira","family":"Drzyma\u0142a-Czy\u017c","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Walkowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Alicandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav Trond","family":"Storr\u00f6sten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnhild","family":"Kolsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egil","family":"Bakkeheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5323-8272","authenticated-orcid":false,"given":"Birgitta","family":"Strandvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.111153_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/14712598.2018.1484101","article-title":"Unmet needs in cystic fibrosis","volume":"18","author":"Rubin","year":"2018","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.isci.2024.111153_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/17476348.2018.1483723","article-title":"Unmet needs in cystic fibrosis: the next steps in improving outcomes","volume":"12","author":"West","year":"2018","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.isci.2024.111153_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1210\/me.2008-0398","article-title":"Minireview: liver X receptor beta: emerging roles in physiology and diseases","volume":"23","author":"Gabbi","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.isci.2024.111153_bib4","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00024.2021","article-title":"Liver X receptor \u03b2 regulates bile volume and the expression of aquaporins and cystic fibrosis transmembrane conductance regulator in the gallbladder","volume":"321","author":"Sweed","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nm1028","article-title":"Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice","volume":"10","author":"Mall","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.111153_bib6","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00431-021-04168-y","article-title":"A new era for people with cystic fibrosis","volume":"180","author":"Bierlaagh","year":"2021","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.isci.2024.111153_bib7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/cells11071243","article-title":"CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis","volume":"11","author":"Saluzzo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.isci.2024.111153_bib8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ccm.2022.06.011","article-title":"Non-Modulator Therapies: Developing a Therapy for Every Cystic Fibrosis Patient","volume":"43","author":"Egan","year":"2022","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.isci.2024.111153_bib9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41467-023-36244-2","article-title":"Future therapies for cystic fibrosis","volume":"14","author":"Allen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.111153_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcf.2021.03.016","article-title":"Peripheral lung effect of elexacaftor\/tezacaftor\/ivacaftor in adult cystic fibrosis","volume":"21","author":"Stylemans","year":"2022","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib11","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.111153_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-med-042921-021447","article-title":"Cystic Fibrosis Modulator Therapies","volume":"74","author":"Jia","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.isci.2024.111153_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcped.2022.11.019","article-title":"CFTR pharmacological modulators: A great advance in cystic fibrosis management","volume":"30","author":"Foucaud","year":"2023","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.isci.2024.111153_bib14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/children10030554","article-title":"Efficacy and Safety of Elexacaftor-Tezacaftor-Ivacaftor in the Treatment of Cystic Fibrosis: A Systematic Review","volume":"10","author":"Kapouni","year":"2023","journal-title":"Children"},{"key":"10.1016\/j.isci.2024.111153_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12013-023-01200-w","article-title":"Understanding CFTR Functionality: A Comprehensive Review of Tests and Modulator Therapy in Cystic Fibrosis","volume":"82","author":"Thakur","year":"2024","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.isci.2024.111153_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1176815","article-title":"Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis","volume":"14","author":"Olivier","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2024.111153_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.isci.2024.111153_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40272-022-00509-y","article-title":"An Update on CFTR Modulators as New Therapies for Cystic Fibrosis","volume":"24","author":"King","year":"2022","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.isci.2024.111153_bib19","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0140-6736(23)01608-2","article-title":"The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches","volume":"402","author":"Graeber","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2024.111153_bib20","doi-asserted-by":"crossref","first-page":"2003502","DOI":"10.1183\/13993003.03502-2020","article-title":"Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages","volume":"57","author":"Gillan","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.isci.2024.111153_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.24129","article-title":"Inflammation in cystic fibrosis: An update","volume":"53","author":"Roesch","year":"2018","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.isci.2024.111153_bib22","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.3390\/ijms22041952","article-title":"Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches","volume":"22","author":"Ghigo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.111153_bib23","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/17476348.2019.1666715","article-title":"Targeting airway inflammation in cystic fibrosis","volume":"13","author":"McElvaney","year":"2019","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.isci.2024.111153_bib24","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0140-6736(23)01727-0","article-title":"Are we there yet? The ongoing journey of cystic fibrosis care","volume":"402","author":"Perrem","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2024.111153_bib25","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.3390\/ijms21176379","article-title":"Airway Inflammation and Host Responses in the Era of CFTR Modulators","volume":"21","author":"Keown","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.111153_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1164\/rccm.202008-3176LE","article-title":"Safety and Efficacy of Elexacaftor\/Tezacaftor\/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phase 3 Clinical Trial","volume":"203","author":"Griese","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.isci.2024.111153_bib27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/rccm.202110-2249OC","article-title":"Effects of Elexacaftor\/Tezacaftor\/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles","volume":"205","author":"Graeber","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.isci.2024.111153_bib28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/cod.14002","article-title":"Toxic epidermal necrolysis induced by cystic fibrosis transmembrane conductance regulator modulators","volume":"86","author":"Mederos-Luis","year":"2022","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.isci.2024.111153_bib29","article-title":"Delayed hepatic necrosis in a cystic fibrosis patient taking Elexacaftor\/Tezacaftor\/Ivacaftor (Kaftrio)","volume":"34","author":"Salehi","year":"2021","journal-title":"Respir. Med. Case Rep."},{"key":"10.1016\/j.isci.2024.111153_bib30","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.psym.2020.06.021","article-title":"Trikafta and Psychopathology in Cystic Fibrosis: A Case Report","volume":"61","author":"Tindell","year":"2020","journal-title":"Psychosomatics"},{"key":"10.1016\/j.isci.2024.111153_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib32","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jcf.2023.10.002","article-title":"Alterations in lipids after initiation of highly effective modulators in people with cystic fibrosis","volume":"22","author":"Despotes","year":"2023","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jcf.2021.10.002","article-title":"Mental status changes during elexacaftor\/tezacaftor\/ivacaftor therapy","volume":"21","author":"Heo","year":"2022","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib34","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jcf.2022.05.001","article-title":"Dose adjustments of Elexacaftor\/Tezacaftor\/Ivacaftor in response to mental health side effects in adults with cystic fibrosis","volume":"21","author":"Spoletini","year":"2022","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib35","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/ppul.26412","article-title":"Management of neuropsychiatric symptoms in adults treated with elexacaftor\/tezacaftor\/ivacaftor","volume":"58","author":"Baroud","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.isci.2024.111153_bib36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jcf.2023.01.015","article-title":"Suicide attempts in adolescents with cystic fibrosis on Elexacaftor\/Tezacaftor\/Ivacaftor therapy","volume":"22","author":"Arslan","year":"2023","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib37","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/ppul.26527","article-title":"Positive and negative impacts of elexacaftor\/tezacaftor\/ivacaftor: Healthcare providers' observations across US centers","volume":"58","author":"Bathgate","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.isci.2024.111153_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcf.2023.12.002","article-title":"Standards for the care of people with cystic fibrosis; establishing and maintaining health","volume":"23","author":"Southern","year":"2024","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jcf.2016.07.006","article-title":"The effects of ivacaftor on CF fatty acid metabolism: An analysis from the GOAL study","volume":"16","author":"O'Connor","year":"2017","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib40","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1021\/acs.jproteome.0c00556","article-title":"Lipidome Alterations Induced by Cystic Fibrosis, CFTR Mutation, and Lung Function","volume":"20","author":"Zardini Buzatto","year":"2021","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.isci.2024.111153_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102239","article-title":"Current state of CFTR modulators for treatment of Cystic Fibrosis","volume":"65","author":"Despotes","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.isci.2024.111153_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.619442","article-title":"CFTR Correctors and Antioxidants Partially Normalize Lipid Imbalance but not Abnormal Basal Inflammatory Cytokine Profile in CF Bronchial Epithelial Cells","volume":"12","author":"Veltman","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib43","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.3390\/ijms21155439","article-title":"Proteomics and Metabolomics for Cystic Fibrosis Research","volume":"21","author":"Liessi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.111153_bib44","doi-asserted-by":"crossref","first-page":"jcs259002","DOI":"10.1242\/jcs.259002","article-title":"Lipid-driven CFTR clustering is impaired in cystic fibrosis and restored by corrector drugs","volume":"135","author":"Abu-Arish","year":"2022","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.isci.2024.111153_bib59","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.bbamem.2016.02.037","article-title":"Lipid interaction sites on channels, transporters and receptors: Recent insights from molecular dynamics simulations","volume":"1858","author":"Hedger","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.isci.2024.111153_bib60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S1464793104006578","article-title":"Dietary fats and membrane function: implications for metabolism and disease","volume":"80","author":"Hulbert","year":"2005","journal-title":"Biol. Rev. Camb. Phil. Soc."},{"key":"10.1016\/j.isci.2024.111153_bib61","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1194\/jlr.R120000800","article-title":"Roles of polyunsaturated fatty acids, from mediators to membranes","volume":"61","author":"Harayama","year":"2020","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.isci.2024.111153_bib62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.biophys.36.040306.132643","article-title":"Bilayer thickness and membrane protein function: an energetic perspective","volume":"36","author":"Andersen","year":"2007","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.isci.2024.111153_bib63","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature08147","article-title":"Emerging roles for lipids in shaping membrane-protein function","volume":"459","author":"Phillips","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.111153_bib64","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.bbamem.2017.04.003","article-title":"Towards understanding the molecular basis of ion channel modulation by lipids: Mechanistic models and current paradigms","volume":"1859","author":"Poveda","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.isci.2024.111153_bib65","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1093\/jn\/130.12.2870","article-title":"The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells","volume":"130","author":"Bhura-Bandali","year":"2000","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib66","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbalip.2011.05.002","article-title":"Increased \u03945- and \u03946-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosis","volume":"1811","author":"Njoroge","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.isci.2024.111153_bib67","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1203\/00006450-198408000-00005","article-title":"Abnormal fatty acid turnover in the phospholipids of the red blood cell membranes of cystic fibrosis patients (in\u00a0vitro study)","volume":"18","author":"Rogiers","year":"1984","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.isci.2024.111153_bib68","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11745-011-3563-z","article-title":"Increased elongase 6 and \u03949-desaturase activity are associated with n-7 and n-9 fatty acid changes in cystic fibrosis","volume":"46","author":"Thomsen","year":"2011","journal-title":"Lipids"},{"key":"10.1016\/j.isci.2024.111153_bib69","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0009-8981(94)90263-1","article-title":"Cystic fibrosis and phosphatidylcholine biosynthesis","volume":"230","author":"Ulane","year":"1994","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.isci.2024.111153_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007735","article-title":"A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients","volume":"4","author":"Guerrera","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.111153_bib71","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1067\/mpd.2001.118890","article-title":"Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis","volume":"139","author":"Strandvik","year":"2001","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.isci.2024.111153_bib72","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(77)90359-2","article-title":"Abnormal fatty-acid composition of plasma-lipids in cystic fibrosis. A primary or a secondary defect?","volume":"2","author":"Hubbard","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2024.111153_bib73","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(78)91620-3","article-title":"Fatty-acid composition of serum-lecithins in cystic-fibrosis patients without steatorrhoea","volume":"2","author":"Galabert","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2024.111153_bib45","doi-asserted-by":"crossref","first-page":"e138722","DOI":"10.1172\/jci.insight.138722","article-title":"Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta","volume":"5","author":"Liessi","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2024.111153_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bpj.2015.04.042","article-title":"Cholesterol modulates CFTR confinement in the plasma membrane of primary epithelial cells","volume":"109","author":"Abu-Arish","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.isci.2024.111153_bib47","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1085\/jgp.201812143","article-title":"Agonists that stimulate secretion promote the recruitment of CFTR into membrane lipid microdomains","volume":"151","author":"Abu-Arish","year":"2019","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib48","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jcf.2023.04.012","article-title":"The combination elexacaftor\/tezacaftor\/ivacaftor (ETI) modulates the de novo synthethic pathway of ceramides in a genotype-independent manner","volume":"22","author":"Liessi","year":"2023","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2022.184078","article-title":"Impact of cholesterol and Lumacaftor on the folding of CFTR helical hairpins","volume":"1865","author":"Schenkel","year":"2023","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.isci.2024.111153_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.876842","article-title":"Treatment With LAU-7b Complements CFTR Modulator Therapy by Improving Lung Physiology and Normalizing Lipid Imbalance Associated With CF Lung Disease","volume":"13","author":"Centorame","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2024.111153_bib51","doi-asserted-by":"crossref","first-page":"e174500","DOI":"10.1172\/JCI174500","article-title":"Arteriovenous metabolomics in pigs reveals CFTR regulation of metabolism in multiple organs","volume":"134","author":"Bae","year":"2024","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2024.111153_bib52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/phar.2903","article-title":"Real world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis","volume":"44","author":"Lonabaugh","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.isci.2024.111153_bib53","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/ppul.26823","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on lipid and fat-soluble vitamin levels and association with body mass index","volume":"59","author":"Patel","year":"2024","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.isci.2024.111153_bib54","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jcf.2023.04.010","article-title":"Changes in nutrition and growth status in young children in the first 12\u00a0weeks of ivacaftor therapy","volume":"22","author":"Tindall","year":"2023","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib55","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jcf.2024.05.005","article-title":"Impact of lumacaftor\/ivacaftor on nutrition and growth in modulator-na\u00efve children over 24\u00a0weeks","volume":"23","author":"Tindall","year":"2024","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib56","article-title":"Essential fatty acid and lipoprotien status in pediatric cystic fibrosis: Impact of cystic fibrosis transmembrane conductoance regulator modulators","volume":"21S2","author":"McDonald","year":"2022","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib57","doi-asserted-by":"crossref","first-page":"e70000","DOI":"10.1002\/cti2.70000","article-title":"The Omega-6 lipid pathway shift is associated with neutrophil influx and structural lung damage in early cystic fibrosis lung disease","volume":"13","author":"Slimmen","year":"2024","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.isci.2024.111153_bib58","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jcf.2023.07.001","article-title":"Improvement of lipid and lipoprotein profiles in children and adolescents with cystic fibrosis on CFTR modulator therapy","volume":"22","author":"Yuzyuk","year":"2023","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib74","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1021\/bi00803a003","article-title":"Phopholipid class and fatty acid composition of Golgi apparatus isolated from rat liver and comparison with other cell fractions","volume":"9","author":"Keenan","year":"1970","journal-title":"Biochemistry"},{"key":"10.1016\/j.isci.2024.111153_bib75","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/00365518809085746","article-title":"Effects of unsaturated fatty acids on cell membrane functions","volume":"48","author":"Hagve","year":"1988","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.isci.2024.111153_bib76","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbamem.2004.05.012","article-title":"How lipids affect the activities of integral membrane proteins","volume":"1666","author":"Lee","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.isci.2024.111153_bib77","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/BST0390761","article-title":"Lipid-protein interactions","volume":"39","author":"Lee","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.isci.2024.111153_bib78","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-3476(62)80065-1","article-title":"The fatty acid composition of the serum chylomicrons and adipose tissue of children with cystic fibrosis of the pancreas","volume":"60","author":"Kuo","year":"1962","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.isci.2024.111153_bib79","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1749-6632.1972.tb27879.x","article-title":"Polyunsaturated fatty acids and tocopherol levels in patients with cystic fibrosis","volume":"203","author":"Underwood","year":"1972","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.isci.2024.111153_bib80","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1203\/00006450-198601000-00010","article-title":"Correction of linoleic acid deficiency in cystic fibrosis","volume":"20","author":"Mischler","year":"1986","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.isci.2024.111153_bib81","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJMoa021218","article-title":"Association of cystic fibrosis with abnormalities in fatty acid metabolism","volume":"350","author":"Freedman","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.111153_bib82","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.biochem.66.1.199","article-title":"Molecular basis for membrane phospholipid diversity: why are there so many lipids?","volume":"66","author":"Dowhan","year":"1997","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.isci.2024.111153_bib83","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm.2017.138","article-title":"Understanding the diversity of membrane lipid composition","volume":"19","author":"Harayama","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2024.111153_bib84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0163-7827(86)90008-1","article-title":"Nutritional and biochemical evidences of acyl interaction with respect to essential polyunsaturated fatty acids","volume":"25","author":"Holman","year":"1986","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.isci.2024.111153_bib85","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1388-1981(00)00121-9","article-title":"Essential fatty acid deficiency affects the fatty acid composition of the rat small intestinal and colonic mucosa differently","volume":"1487","author":"Korotkova","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.isci.2024.111153_bib86","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/01.mpg.0000228107.98863.45","article-title":"Abnormal fatty acid pattern in intestinal mucosa of children with celiac disease is not reflected in serum phospholipids","volume":"43","author":"Steel","year":"2006","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100894","article-title":"The Atlas of Inflammation Resolution (AIR)","volume":"74","author":"Serhan","year":"2020","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.isci.2024.111153_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5223\/pghn.2022.25.1.1","article-title":"Fecal Calprotectin and Phenotype Severity in Patients with Cystic Fibrosis: A Systematic Review and Meta-Analysis","volume":"25","author":"Talebi","year":"2022","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib89","first-page":"39","article-title":"The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis","volume":"4","author":"Becker","year":"2010","journal-title":"Open Respir. Med. J."},{"key":"10.1016\/j.isci.2024.111153_bib90","article-title":"Ceramide in cystic fibrosis: a potential new target for therapeutic intervention","volume":"2011","author":"Wojewodka","year":"2011","journal-title":"J.\u00a0Lipids"},{"key":"10.1016\/j.isci.2024.111153_bib91","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1165\/rcmb.2008-0279OC","article-title":"Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide","volume":"41","author":"Guilbault","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.isci.2024.111153_bib92","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1164\/rccm.202006-2362ED","article-title":"Membrane Lipids and CFTR: The Yin\/Yang of Efficient Ceramide Metabolism","volume":"202","author":"Bonfield","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.isci.2024.111153_bib93","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0929-693X(09)74060-6","article-title":"[Cystic fibrosis, fatty acid imbalance, ceramide and lipid rafts]","volume":"16","author":"Chanson","year":"2009","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.isci.2024.111153_bib94","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1164\/ajrccm.183.1.133","article-title":"Ceramide and cystic fibrosis lung disease","volume":"183","author":"Brodlie","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.isci.2024.111153_bib95","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/164_2023_700","article-title":"New Therapeutic Options in Pulmonal Diseases: Sphingolipids and Modulation of Sphingolipid Metabolism","volume":"284","author":"Kleuser","year":"2023","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.isci.2024.111153_bib96","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1194\/jlr.M800427-JLR200","article-title":"Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling","volume":"50","author":"Hamai","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.isci.2024.111153_bib97","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1007\/s00018-020-03530-x","article-title":"The role of essential fatty acids in cystic fibrosis and normalizing effect of fenretinide","volume":"77","author":"Gari\u0107","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2024.111153_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2023.102590","article-title":"Decreased plasma levels of sphingolipids and total cholesterol in adult cystic fibrosis patients","volume":"197","author":"Bal Topcu","year":"2023","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245302","article-title":"Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study","volume":"16","author":"Amato","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.111153_bib100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.abb.2011.08.012","article-title":"Molecular pathways for intracellular cholesterol accumulation: common pathogenic mechanisms in Niemann-Pick disease Type C and cystic fibrosis","volume":"515","author":"Cianciola","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.isci.2024.111153_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.652513","article-title":"Alteration of Membrane Cholesterol Content Plays a Key Role in Regulation of Cystic Fibrosis Transmembrane Conductance Regulator Channel Activity","volume":"12","author":"Cui","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib102","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3390\/cells8080804","article-title":"Cholesterol Interaction Directly Enhances Intrinsic Activity of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)","volume":"8","author":"Chin","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.isci.2024.111153_bib103","doi-asserted-by":"crossref","first-page":"L476","DOI":"10.1152\/ajplung.00262.2006","article-title":"Altered cholesterol homeostasis in cultured and in\u00a0vivo models of cystic fibrosis","volume":"292","author":"White","year":"2007","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib104","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-11-61","article-title":"Increased plasma membrane cholesterol in cystic fibrosis cells correlates with CFTR genotype and depends on de novo cholesterol synthesis","volume":"11","author":"Fang","year":"2010","journal-title":"Respir. Res."},{"key":"10.1016\/j.isci.2024.111153_bib105","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1515\/cclm-2015-1151","article-title":"Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis: a preliminary study of plasma sterols","volume":"54","author":"Gelzo","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.isci.2024.111153_bib106","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jcf.2018.06.005","article-title":"Electrochemical measurement of membrane cholesterol correlates with CFTR function and is HDAC6-dependent","volume":"18","author":"Lu","year":"2019","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib107","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cmet.2013.10.002","article-title":"LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition","volume":"18","author":"Rong","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.isci.2024.111153_bib108","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.plefa.2010.07.002","article-title":"Fatty acid metabolism in cystic fibrosis","volume":"83","author":"Strandvik","year":"2010","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib109","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/00365528809090234","article-title":"Status of plasma and erythrocyte fatty acids and vitamin A and E in young children with cystic fibrosis","volume":"143","author":"Biggemann","year":"1988","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"10.1016\/j.isci.2024.111153_bib110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF02536629","article-title":"Serum fatty acid profiles in cystic fibrosis patients and their parents","volume":"29","author":"Christophe","year":"1994","journal-title":"Lipids"},{"key":"10.1016\/j.isci.2024.111153_bib111","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ajcn\/54.6.1029","article-title":"Essential fatty acid status and fluidity of plasma phospholipids in cystic fibrosis infants","volume":"54","author":"Lloyd-Still","year":"1991","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib112","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0009-8981(80)90098-4","article-title":"Altered phospholipid composition and changed fatty acid pattern of the various phospholipid fractions of red cell membranes of cystic fibrosis children with pancreatic insufficiency","volume":"105","author":"Rogiers","year":"1980","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.isci.2024.111153_bib113","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1203\/00006450-198009000-00015","article-title":"Long chain non-esterified fatty acid pattern in plasma of cystic fibrosis patients and their parents","volume":"14","author":"Rogiers","year":"1980","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.isci.2024.111153_bib114","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00445666","article-title":"Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency","volume":"141","author":"Rogiers","year":"1983","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.isci.2024.111153_bib115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00540261","article-title":"Fatty acid pattern of platelet phospholipids in cystic fibrosis","volume":"142","author":"Rogiers","year":"1984","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.isci.2024.111153_bib116","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/MPG.0b013e31817fb76b","article-title":"Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis","volume":"47","author":"Maqbool","year":"2008","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib117","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1373\/clinchem.2007.094623","article-title":"Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis","volume":"54","author":"Coste","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.isci.2024.111153_bib118","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.mpg.0000235978.59873.04","article-title":"Dietary and circulating polyunsaturated fatty acids in cystic fibrosis: are they related to clinical outcomes?","volume":"43","author":"Colombo","year":"2006","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib119","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/MPG.0b013e3180690da9","article-title":"Polyunsaturated fatty acids in cystic fibrosis are related to nutrition and clinical expression of the disease","volume":"45","author":"Walkowiak","year":"2007","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1542\/peds.105.1.53","article-title":"Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening","volume":"105","author":"Lai","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.isci.2024.111153_bib121","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1079\/BJN20051655","article-title":"Serum phospholipid fatty acid profile and dietary intake in an adult Mediterranean population with cystic fibrosis","volume":"96","author":"Olveira","year":"2006","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib122","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.clinbiochem.2007.01.002","article-title":"An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis","volume":"40","author":"Coste","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.isci.2024.111153_bib123","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1542\/peds.59.3.428","article-title":"Dietary essential fatty acids in cystic fibrosis","volume":"59","author":"Rosenlund","year":"1977","journal-title":"Pediatrics"},{"key":"10.1016\/j.isci.2024.111153_bib124","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0140-6736(75)90121-X","article-title":"Defective essential-fatty-acid metabolism in cystic fibrosis","volume":"2","author":"Rivers","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2024.111153_bib125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1203\/00006450-198501000-00028","article-title":"Fatty acid abnormalities in cystic fibrosis","volume":"19","author":"Farrell","year":"1985","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.isci.2024.111153_bib126","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1042\/CS20220450","article-title":"The fatty acid imbalance of cystic fibrosis exists at birth independent of feeding in pig and ferret models","volume":"136","author":"Uc","year":"2022","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.isci.2024.111153_bib127","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/MPG.0b013e3182618f33","article-title":"Relation between dietary fat intake type and serum fatty acid status in children with cystic fibrosis","volume":"55","author":"Maqbool","year":"2012","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib128","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1159\/000114208","article-title":"Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients","volume":"51","author":"Van Biervliet","year":"2007","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.isci.2024.111153_bib129","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.3390\/nu14214666","article-title":"Essential Fatty Acid Deficiency in Cystic Fibrosis Disease Progression: Role of Genotype and Sex","volume":"14","author":"Shrestha","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.isci.2024.111153_bib130","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1515\/CCLM.2010.336","article-title":"Fatty acid composition of serum phospholipids in cystic fibrosis (CF) patients with or without CF related liver disease","volume":"48","author":"Van Biervliet","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.isci.2024.111153_bib131","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000477913","article-title":"Serum Phospholipid Fatty Acid Composition in Cystic Fibrosis Patients with and without Liver Cirrhosis","volume":"71","author":"Drzyma\u0142a-Czy\u017c","year":"2017","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.isci.2024.111153_bib132","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jcf.2010.03.002","article-title":"Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease","volume":"9","author":"Ris\u00e9","year":"2010","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib133","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jn\/70.3.405","article-title":"The ratio of trienoic: tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement","volume":"70","author":"Holman","year":"1960","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib134","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1373\/clinchem.2006.077008","article-title":"Potential utility of plasma fatty acid analysis in the diagnosis of cystic fibrosis","volume":"53","author":"Batal","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.isci.2024.111153_bib135","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/apa.1989.78.s363.58","article-title":"Relation between essential fatty acid metabolism and gastrointestinal symptoms in cystic fibrosis","volume":"363","author":"Strandvik","year":"1989","journal-title":"Acta Paediatr. Scand. Suppl."},{"key":"10.1016\/j.isci.2024.111153_bib136","series-title":"Polyunsaturated Fatty Acids in Human Nutrition","first-page":"159","article-title":"Long chain fatty acid metabolism and essential fatty acid deficiency with special emphasis on cystic fibrosis","author":"Strandvik","year":"1992"},{"key":"10.1016\/j.isci.2024.111153_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102156","article-title":"Abnormal n-6 fatty acid metabolism in cystic fibrosis contributes to pulmonary symptoms","volume":"160","author":"Wheelock","year":"2020","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib138","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1743-7075-8-36","article-title":"Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review","volume":"8","author":"Rett","year":"2011","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.isci.2024.111153_bib139","first-page":"1029-41","article-title":"Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials","volume":"112","author":"Johnson","year":"2012","journal-title":"J.\u00a0Acad. Nutr. Diet."},{"key":"10.1016\/j.isci.2024.111153_bib140","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/jn\/137.4.945","article-title":"Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men","volume":"137","author":"Liou","year":"2007","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib141","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000068906","article-title":"Influence of dietary linoleic acid intake with different fat intakes on arachidonic acid concentrations in plasma and platelet lipids and eicosanoid biosynthesis in female volunteers","volume":"47","author":"Adam","year":"2003","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.isci.2024.111153_bib142","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/j.clnesp.2015.12.001","article-title":"Essential fatty acid composition and correlates in children with severe acute malnutrition","volume":"11","author":"Babirekere-Iriso","year":"2016","journal-title":"Clin. Nutr. ESPEN"},{"key":"10.1016\/j.isci.2024.111153_bib143","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1651-2227.2003.tb00512.x","article-title":"The predominance of omega-6 polyunsaturated fatty acids in cystic fibrosis despite low arachidonic acid levels","volume":"92","author":"Walkowiak","year":"2003","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.isci.2024.111153_bib144","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1542\/peds.2004-2832","article-title":"Temporal associations among energy intake, plasma linoleic acid, and growth improvement in response to treatment initiation after diagnosis of cystic fibrosis","volume":"117","author":"Shoff","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.isci.2024.111153_bib145","doi-asserted-by":"crossref","first-page":"13995","DOI":"10.1073\/pnas.96.24.13995","article-title":"A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-\/-) mice","volume":"96","author":"Freedman","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.111153_bib146","doi-asserted-by":"crossref","first-page":"G839","DOI":"10.1152\/ajpgi.00582.2005","article-title":"Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis","volume":"292","author":"Beharry","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib147","article-title":"Omega-3 fatty acid supplementation for cystic fibrosis","volume":"4","author":"Watson","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.isci.2024.111153_bib148","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/ppul.26491","article-title":"Impact of omega-3 supplementation on children and adolescents patients with cystic fibrosis: A systematic review and meta-analysis of randomized-controlled trials","volume":"58","author":"Sohouli","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.isci.2024.111153_bib149","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/014860710302700152","article-title":"Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis","volume":"27","author":"De Vizia","year":"2003","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib150","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1535370218758605","article-title":"Low linoleic and high docosahexaenoic acids in a severe phenotype of transgenic cystic fibrosis mice","volume":"243","author":"Strandvik","year":"2018","journal-title":"Exp. Biol. Med. (Maywood, NJ, U. S.)"},{"key":"10.1016\/j.isci.2024.111153_bib151","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1067\/S0022-3476(03)00326-3","article-title":"Increased plasma homocysteine and S-adenosylhomocysteine and decreased methionine is associated with altered phosphatidylcholine and phosphatidylethanolamine in cystic fibrosis","volume":"143","author":"Innis","year":"2003","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.isci.2024.111153_bib152","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.3390\/ijms19102865","article-title":"Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis","volume":"19","author":"Philippe","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.111153_bib153","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3389\/fphar.2020.01129","article-title":"The Resolution Approach to Cystic Fibrosis Inflammation","volume":"11","author":"Recchiuti","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2024.111153_bib154","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-3-7091-1511-4_13","article-title":"Ceramide in cystic fibrosis","volume":"216","author":"Grassm\u00e9","year":"2013","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.isci.2024.111153_bib155","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.plipres.2019.03.001","article-title":"Biochemistry of very-long-chain and long-chain ceramides in cystic fibrosis and other diseases: The importance of side chain","volume":"74","author":"Gari\u0107","year":"2019","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.isci.2024.111153_bib156","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nm1748","article-title":"Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis","volume":"14","author":"Teichgr\u00e4ber","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.111153_bib157","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/2211-5463.13660","article-title":"Cross-talk between CFTR and sphingolipids in cystic fibrosis","volume":"13","author":"Dobi","year":"2023","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.isci.2024.111153_bib158","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00109-017-1564-y","article-title":"Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside","volume":"95","author":"Gari\u0107","year":"2017","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.isci.2024.111153_bib159","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00408-020-00353-2","article-title":"Age-Dependent Progression in Lung Pathophysiology can be Prevented by Restoring Fatty Acid and Ceramide Imbalance in Cystic Fibrosis","volume":"198","author":"Youssef","year":"2020","journal-title":"Lung"},{"key":"10.1016\/j.isci.2024.111153_bib160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2017.08.013","article-title":"Neutrophil Membrane Cholesterol Content is a Key Factor in Cystic Fibrosis Lung Disease","volume":"23","author":"White","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2024.111153_bib161","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/biom11020313","article-title":"Severe Genotype, Pancreatic Insufficiency and Low Dose of Pancreatic Enzymes Associate with Abnormal Serum Sterol Profile in Cystic Fibrosis","volume":"11","author":"Drzyma\u0142a-Czy\u017c","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.isci.2024.111153_bib162","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3945\/ajcn.2009.27757","article-title":"Association of cholesterol oxidation and abnormalities in fatty acid metabolism in cystic fibrosis","volume":"90","author":"Iuliano","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib163","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbrc.2013.11.077","article-title":"Action mechanisms of Liver X Receptors","volume":"446","author":"Gabbi","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.isci.2024.111153_bib164","doi-asserted-by":"crossref","first-page":"15052","DOI":"10.1073\/pnas.0808097105","article-title":"Pancreatic exocrine insufficiency in LXRbeta-\/- mice is associated with a reduction in aquaporin-1 expression","volume":"105","author":"Gabbi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.111153_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166121","article-title":"Liver X receptors and liver physiology","volume":"1867","author":"Russo-Savage","year":"2021","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.isci.2024.111153_bib166","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.plefa.2005.04.009","article-title":"LXR is crucial in lipid metabolism","volume":"73","author":"Ulven","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib167","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ppul.25158","article-title":"Cystic fibrosis year in review 2019: Section 3 multisystem-based care and research","volume":"58","author":"Savant","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.isci.2024.111153_bib168","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/apa.15155","article-title":"Cystic fibrosis in the year 2020: A disease with a new face","volume":"109","author":"De Boeck","year":"2020","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.isci.2024.111153_bib169","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1513\/pats.200703-043BR","article-title":"Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials","volume":"4","author":"Rowe","year":"2007","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.isci.2024.111153_bib170","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/thx.2008.104752","article-title":"Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis","volume":"64","author":"Goubau","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.isci.2024.111153_bib171","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2024.111153_bib172","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jcf.2020.07.023","volume":"20","author":"Davies","year":"2021","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib173","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S2213-2600(22)00504-5","article-title":"Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials","volume":"11","author":"Uluer","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.isci.2024.111153_bib174","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/j.1536-4801.1983.tb08523.x","article-title":"Prospective study of fatty acid supplementation over 3 years in patients with cystic fibrosis","volume":"2","author":"Kusoffsky","year":"1983","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/adc.50.1.76","article-title":"Unusual clinical course in a child with cystic fibrosis treated with fat emulsion","volume":"50","author":"Elliott","year":"1975","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.isci.2024.111153_bib176","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1542\/peds.57.4.474","article-title":"A therapeutic trial of fatty acid supplementation in cystic fibrosis","volume":"57","author":"Elliott","year":"1976","journal-title":"Pediatrics"},{"key":"10.1016\/j.isci.2024.111153_bib177","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1079\/BJN19900113","article-title":"Paradoxical effects of essential fatty acid supplementation on lipid profiles and sweat electrolytes in cystic fibrosis","volume":"63","author":"Dodge","year":"1990","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib178","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00424-002-0959-x","article-title":"Functional interaction of CFTR and ENaC in sweat glands","volume":"445","author":"Reddy","year":"2003","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.isci.2024.111153_bib179","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/bph.13533","article-title":"The function and regulation of acid-sensing ion channels (ASICs) and the epithelial Na(+) channel (ENaC): IUPHAR Review 19","volume":"173","author":"Boscardin","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.isci.2024.111153_bib180","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ajcn\/63.5.746","article-title":"Effect of linoleic acid intake on growth of infants with cystic fibrosis","volume":"63","author":"van Egmond","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib181","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ajcn\/69.3.531","article-title":"Comparison of growth status of patients with cystic fibrosis between the United States and Canada","volume":"69","author":"Lai","year":"1999","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib182","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MPG.0000000000001956","article-title":"Nutritional Status in the First 2 Years of Life in Cystic Fibrosis Diagnosed by Newborn Screening","volume":"67","author":"Munck","year":"2018","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib183","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.clnu.2013.07.011","article-title":"Dietary intake in children and adolescents with cystic fibrosis","volume":"33","author":"Woestenenk","year":"2014","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib184","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jpeds.2005.06.003","article-title":"Overweight and obesity in deltaF508 homozygous cystic fibrosis","volume":"147","author":"Kastner-Cole","year":"2005","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.isci.2024.111153_bib185","article-title":"Obesity in cystic fibrosis","volume":"26","author":"Kutney","year":"2021","journal-title":"J.\u00a0Clin. Transl. Endocrinol."},{"key":"10.1016\/j.isci.2024.111153_bib186","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/ppul.26641","article-title":"Cystic fibrosis year in review 2022","volume":"58","author":"Kim","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.isci.2024.111153_bib187","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-8223(95)00121-2","article-title":"Oral supplementation with a high-fat, high-energy product improves nutritional status and alters serum lipids in patients with cystic fibrosis","volume":"95","author":"Rettammel","year":"1995","journal-title":"J.\u00a0Am. Diet Assoc."},{"key":"10.1016\/j.isci.2024.111153_bib188","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/00365528809090239","article-title":"Food intake in patients with cystic fibrosis on an ordinary diet","volume":"143","author":"Kindstedt-Arfwidson","year":"1988","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"10.1016\/j.isci.2024.111153_bib189","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/jn\/91.4.528","article-title":"Metabolism of linoleic acid in relation to dietary saturated fatty acids in the rat","volume":"91","author":"Mohrhauer","year":"1967","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib190","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-2275(20)37247-3","article-title":"Pure linoleate deficiency in the rat: influence on growth, accumulation of n-6 polyunsaturates, and [1-14C]linoleate oxidation","volume":"38","author":"Cunnane","year":"1997","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.isci.2024.111153_bib191","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1651-2227.1985.tb14932.x","article-title":"The nutritional state and nutrition","volume":"317","author":"Dodge","year":"1985","journal-title":"Acta Paediatr. Scand. Suppl."},{"key":"10.1016\/j.isci.2024.111153_bib192","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/1099800416643585","article-title":"Growth Deficiency in Cystic Fibrosis Is Observable at Birth and Predictive of Early Pulmonary Function","volume":"18","author":"Darrah","year":"2016","journal-title":"Biol. Res. Nurs."},{"key":"10.1016\/j.isci.2024.111153_bib193","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jcf.2018.01.006","article-title":"Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis","volume":"17","author":"Sanders","year":"2018","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib194","author":"Zolin"},{"key":"10.1016\/j.isci.2024.111153_bib195","author":"Faro"},{"key":"10.1016\/j.isci.2024.111153_bib196","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1542\/peds.2007-3089","article-title":"Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis","volume":"123","author":"Lai","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.isci.2024.111153_bib197","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ppul.20092","article-title":"Longitudinal pulmonary status of cystic fibrosis children with meconium ileus","volume":"38","author":"Li","year":"2004","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.isci.2024.111153_bib198","first-page":"418","article-title":"Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients","volume":"31","author":"Steinkamp","year":"2000","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib199","first-page":"417","article-title":"Insulin-like growth factor-I levels predict weight, height and protein catabolism in children and adolescents with cystic fibrosis","volume":"22","author":"Switzer","year":"2009","journal-title":"J.\u00a0Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.111153_bib200","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4049\/jimmunol.1300221","article-title":"Low levels of insulin-like growth factor-1 contribute to alveolar macrophage dysfunction in cystic fibrosis","volume":"191","author":"Bessich","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2024.111153_bib201","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/07435809809135532","article-title":"Serum leptin and IGF-I levels in cystic fibrosis","volume":"24","author":"Arumugam","year":"1998","journal-title":"Endocr. Res."},{"key":"10.1016\/j.isci.2024.111153_bib202","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/adc.72.6.494","article-title":"Diminished concentrations of insulin-like growth factor I in cystic fibrosis","volume":"72","author":"Laursen","year":"1995","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.isci.2024.111153_bib203","doi-asserted-by":"crossref","first-page":"20571","DOI":"10.1073\/pnas.1015281107","article-title":"Pigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth","volume":"107","author":"Rogan","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.111153_bib204","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/adc.76.4.304","article-title":"Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis","volume":"76","author":"Taylor","year":"1997","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.isci.2024.111153_bib205","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/adc.88.11.956","article-title":"Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients","volume":"88","author":"Sermet-Gaudelus","year":"2003","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.isci.2024.111153_bib206","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1203\/01.pdr.0000196720.25938.be","article-title":"Mouse as a model of growth retardation in cystic fibrosis","volume":"59","author":"Rosenberg","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.isci.2024.111153_bib207","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188497","article-title":"Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat","volume":"12","author":"Stalvey","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.111153_bib208","doi-asserted-by":"crossref","first-page":"e1211-26","DOI":"10.1542\/peds.2010-2007","article-title":"Recombinant human growth hormone in the treatment of patients with cystic fibrosis","volume":"126","author":"Phung","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.isci.2024.111153_bib209","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/abr.abr_285_20","article-title":"Evaluation of Growth Hormone Deficiency in Children with Cystic Fibrosis","volume":"11","author":"Reisi","year":"2022","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.isci.2024.111153_bib210","article-title":"Recombinant growth hormone therapy for cystic fibrosis in children and young adults","volume":"8","author":"Thaker","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.isci.2024.111153_bib211","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MPG.0000000000001691","article-title":"Serum n-6 and n-9 Fatty Acids Correlate With Serum IGF-1 and Growth Up to 4 Months of Age in Healthy Infants","volume":"66","author":"Kjellberg","year":"2018","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib212","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bbalip.2004.10.006","article-title":"Perinatal essential fatty acid deficiency influences body weight and bone parameters in adult male rats","volume":"1686","author":"Korotkova","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.isci.2024.111153_bib213","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1079\/BJN20041252","article-title":"Dietary n-6:n-3 fatty acid ratio in the perinatal period affects bone parameters in adult female rats","volume":"92","author":"Korotkova","year":"2004","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib214","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3476(05)83042-2","article-title":"The cystic fibrosis gene and resting energy expenditure","volume":"119","author":"Fried","year":"1991","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.isci.2024.111153_bib215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/cs0820071","article-title":"Increased energy expenditure in cystic fibrosis is associated with specific mutations","volume":"82","author":"O'Rawe","year":"1992","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.isci.2024.111153_bib216","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1203\/00006450-199610000-00011","article-title":"Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function, and genotype in children with cystic fibrosis","volume":"40","author":"Zemel","year":"1996","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.isci.2024.111153_bib217","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcf.2006.06.001","article-title":"Resting energy expenditure in cystic fibrosis as an indicator of disease severity","volume":"6","author":"Moudiou","year":"2007","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib218","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jpeds.2007.10.021","article-title":"Longitudinal analysis of resting energy expenditure in patients with cystic fibrosis","volume":"152","author":"Magoffin","year":"2008","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.isci.2024.111153_bib219","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.ejcn.1602637","article-title":"Resting energy expenditure in females with cystic fibrosis: is it affected by puberty?","volume":"61","author":"Barclay","year":"2007","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib220","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jcf.2014.01.009","article-title":"Effect of a dietary intervention on growth and energy expenditure in children with cystic fibrosis","volume":"13","author":"Groleau","year":"2014","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib221","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1651-2227.2007.00478.x","article-title":"Effect of exocrine pancreatic function on resting energy expenditure in cystic fibrosis","volume":"96","author":"Moudiou","year":"2007","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.isci.2024.111153_bib222","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jn\/114.2.255","article-title":"The effect of essential fatty acid deficiency on basal respiration and function of liver mitochondria in rats","volume":"114","author":"Rafael","year":"1984","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib223","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"van der Veen","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.isci.2024.111153_bib224","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbalip.2016.06.015","article-title":"Effects of lipids on mitochondrial functions","volume":"1862","author":"M\u00e5rtensson","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.isci.2024.111153_bib225","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.mito.2009.02.003","article-title":"Dysfunction of mitochondria Ca2+ uptake in cystic fibrosis airway epithelial cells","volume":"9","author":"Antigny","year":"2009","journal-title":"Mitochondrion"},{"key":"10.1016\/j.isci.2024.111153_bib226","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.3390\/jcm8111890","article-title":"An Intriguing Involvement of Mitochondria in Cystic Fibrosis","volume":"8","author":"Favia","year":"2019","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.isci.2024.111153_bib227","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ppul.22859","article-title":"Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis","volume":"49","author":"Joseloff","year":"2014","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.isci.2024.111153_bib228","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10863-016-9663-y","article-title":"Characterization of mitochondrial function in cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function","volume":"48","author":"Atlante","year":"2016","journal-title":"J.\u00a0Bioenerg. Biomembr."},{"key":"10.1016\/j.isci.2024.111153_bib229","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3390\/nu10070836","article-title":"CFTR Deletion Confers Mitochondrial Dysfunction and Disrupts Lipid Homeostasis in Intestinal Epithelial Cells","volume":"10","author":"Kleme","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.isci.2024.111153_bib230","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1586\/17476348.2013.834252","article-title":"Mitochondria in lung diseases","volume":"7","author":"Aravamudan","year":"2013","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.isci.2024.111153_bib231","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.redox.2012.11.007","article-title":"CFTR activity and mitochondrial function","volume":"1","author":"Valdivieso","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2024.111153_bib232","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/cells8070728","article-title":"Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects","volume":"8","author":"Paradies","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.isci.2024.111153_bib233","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jcf.2017.06.005","article-title":"Bicarbonate in cystic fibrosis","volume":"16","author":"Kunzelmann","year":"2017","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib234","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/path.4634","article-title":"Pancreatic pathophysiology in cystic fibrosis","volume":"238","author":"Gibson-Corley","year":"2016","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.isci.2024.111153_bib235","doi-asserted-by":"crossref","first-page":"G961","DOI":"10.1152\/ajpgi.00030.2012","article-title":"Pancreatic and biliary secretion are both altered in cystic fibrosis pigs","volume":"303","author":"Uc","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib236","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcf.2021.04.010","article-title":"Lack of CFTR alters the ferret pancreatic ductal epithelial secretome and cellular proteome: Implications for exocrine\/endocrine signaling","volume":"21","author":"Rotti","year":"2022","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib237","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0026-0495(90)90135-Y","article-title":"Pancreatic function in the essential fatty acid deficient rat","volume":"39","author":"Hjelte","year":"1990","journal-title":"Metabolism"},{"key":"10.1016\/j.isci.2024.111153_bib238","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00006676-199704000-00014","article-title":"Endogenous arachidonic acid release and pancreatic amylase secretion","volume":"14","author":"Hou","year":"1997","journal-title":"Pancreas"},{"key":"10.1016\/j.isci.2024.111153_bib239","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0022-3565(25)33113-7","article-title":"Prostaglandin E2 derived from phosphatidylinositol breakdown in the exocrine pancreas facilitates secretion by an action on the ducts","volume":"221","author":"Marshall","year":"1982","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.isci.2024.111153_bib240","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-291X(88)81190-2","article-title":"Linoleic acid is a potent activator of protein kinase C type III-alpha isoform in pancreatic acinar cells; its role in amylase secretion","volume":"153","author":"Wooten","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.isci.2024.111153_bib241","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.3390\/molecules28114316","article-title":"Membrane Lipid Derivatives: Roles of Arachidonic Acid and Its Metabolites in Pancreatic Physiology and Pathophysiology","volume":"28","author":"Ortiz-Plac\u00edn","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2024.111153_bib242","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1292\/jvms.13-0189","article-title":"The natural PPAR agonist linoleic acid stimulated insulin release in the rat pancreas","volume":"75","author":"Lai","year":"2013","journal-title":"J.\u00a0Vet. Med. Sci."},{"key":"10.1016\/j.isci.2024.111153_bib243","article-title":"Linoleic acid but not EPA and DHA correlates to prognostic markers in Scandinavian CF patients","volume":"7","author":"Hjelte","year":"2008","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib244","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jcf.2019.01.009","article-title":"The main mechanism associated with progression of glucose intolerance in older patients with cystic fibrosis is insulin resistance and not reduced insulin secretion capacity","volume":"18","author":"Colomba","year":"2019","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib245","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcf.2013.06.001","article-title":"Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test","volume":"13","author":"Schmid","year":"2014","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib246","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.plefa.2018.03.001","article-title":"Linoleic acid, glycemic control and Type 2 diabetes","volume":"132","author":"Belury","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib247","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.10.009","article-title":"Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et\u00a0al","volume":"19","author":"Olesen","year":"2020","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib248","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.2337\/db14-0810","article-title":"The \u0394F508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Is Associated With Progressive Insulin Resistance and Decreased Functional \u03b2-Cell Mass in Mice","volume":"64","author":"Font\u00e9s","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.isci.2024.111153_bib249","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/CS20140059","article-title":"Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass","volume":"128","author":"Uc","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.isci.2024.111153_bib250","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2337\/db06-0490","article-title":"The role of arachidonic acid and its metabolites in insulin secretion from human islets of langerhans","volume":"56","author":"Persaud","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.isci.2024.111153_bib251","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.plefa.2012.11.009","article-title":"Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules","volume":"88","author":"Das","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib252","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ni1056","article-title":"Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway","volume":"5","author":"Karp","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2024.111153_bib253","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/s41385-018-0070-z","article-title":"Dietary DHA amplifies LXA(4) circuits in tissues and lymph node PMN and is protective in immune-driven dry eye disease","volume":"11","author":"Gao","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.isci.2024.111153_bib254","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/003655201750065852","article-title":"Gastric secretion in cystic fibrosis in relation to the migrating motor complex","volume":"36","author":"Hallberg","year":"2001","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.isci.2024.111153_bib255","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1748-1716.1981.tb06881.x","article-title":"Protection of the rat gastric mucosa by prostaglandin E2: possible relation to stimulation of the alkaline secretion","volume":"113","author":"Kollberg","year":"1981","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.isci.2024.111153_bib256","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/00365528509095830","article-title":"Protection of the gastroduodenal mucosa by prostaglandins","volume":"110","author":"Johansson","year":"1985","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"10.1016\/j.isci.2024.111153_bib257","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0952-3278(96)90125-8","article-title":"Prostanoid biosynthesis in patients with cystic fibrosis","volume":"55","author":"Strandvik","year":"1996","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib258","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.plefa.2013.06.001","article-title":"Quantification of major urinary metabolites of PGE2 and PGD2 in cystic fibrosis: correlation with disease severity","volume":"89","author":"Jabr","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib259","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00128072-200002030-00005","article-title":"Control of malabsorption in cystic fibrosis","volume":"2","author":"Littlewood","year":"2000","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.isci.2024.111153_bib260","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1203\/00006450-199606000-00010","article-title":"Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis","volume":"39","author":"van Elburg","year":"1996","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.isci.2024.111153_bib261","first-page":"290","article-title":"Intestinal permeability in cystic fibrosis in relation to genotype","volume":"25","author":"Hallberg","year":"1997","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib262","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF02543967","article-title":"Effect of essential fatty acid deficiency on lipid composition of basolateral plasma membrane of pig intestinal mucosal cells","volume":"26","author":"Duranthon","year":"1991","journal-title":"Lipids"},{"key":"10.1016\/j.isci.2024.111153_bib263","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1051\/rnd:19910609","article-title":"Effects of a low dietary linoleic acid level on intestinal morphology and enterocyte brush border membrane lipid composition","volume":"31","author":"Christon","year":"1991","journal-title":"Reprod. Nutr. Dev."},{"key":"10.1016\/j.isci.2024.111153_bib264","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1743-7075-2-11","article-title":"Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency","volume":"2","author":"Peretti","year":"2005","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.isci.2024.111153_bib265","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1211\/0022357022881","article-title":"Absorption of taurocholic acid by the ileum of normal and transgenic DeltaF508 cystic fibrosis mice","volume":"56","author":"Hardcastle","year":"2004","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.isci.2024.111153_bib266","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.3390\/ijms24087194","article-title":"Changes in Essential Fatty Acids and Ileal Genes Associated with Metabolizing Enzymes and Fatty Acid Transporters in Rodent Models of Cystic Fibrosis","volume":"24","author":"Shrestha","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.111153_bib267","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1165\/ajrcmb.22.1.3789","article-title":"Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression","volume":"22","author":"Steagall","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.isci.2024.111153_bib268","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/MPG.0b013e31817e0f2c","article-title":"Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine","volume":"47","author":"De Lisle","year":"2008","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib269","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1194\/jlr.M008870","article-title":"Lipid mapping of colonic mucosa by cluster TOF-SIMS imaging and multivariate analysis in cftr knockout mice","volume":"51","author":"Brulet","year":"2010","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.isci.2024.111153_bib270","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1203\/00006450-199802000-00013","article-title":"Ultrastructural lesions in the small bowel of patients with cystic fibrosis","volume":"43","author":"Sbarbati","year":"1998","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.isci.2024.111153_bib271","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1172\/JCI73193","article-title":"Defective goblet cell exocytosis contributes to murine cystic fibrosis-associated intestinal disease","volume":"125","author":"Liu","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2024.111153_bib272","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000538606","article-title":"Improved Nutritional Outcomes and Gastrointestinal Symptoms in Adult Cystic Fibrosis Patients Treated with Elexacaftor\/Tezacaftor\/Ivacaftor","volume":"42","author":"Stastna","year":"2024","journal-title":"Dig. Dis."},{"key":"10.1016\/j.isci.2024.111153_bib273","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00026.2001","article-title":"Electrolyte transport in the mammalian colon: mechanisms and implications for disease","volume":"82","author":"Kunzelmann","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.isci.2024.111153_bib274","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/adc.82.5.394","article-title":"Intestinal inflammation in cystic fibrosis","volume":"82","author":"Smyth","year":"2000","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.isci.2024.111153_bib275","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/jcm8050645","article-title":"Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn's-Like Microbiota Disturbances","volume":"8","author":"Enaud","year":"2019","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.isci.2024.111153_bib276","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.imbio.2016.11.005","article-title":"Severe disease in Cystic Fibrosis and fecal calprotectin levels","volume":"222","author":"Parisi","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.isci.2024.111153_bib277","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MPG.0000000000000683","article-title":"Intestinal inflammation and impact on growth in children with cystic fibrosis","volume":"60","author":"Dhaliwal","year":"2015","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib278","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009753","article-title":"The cystic fibrosis intestine","volume":"3","author":"De Lisle","year":"2013","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.isci.2024.111153_bib279","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00441-013-1734-3","article-title":"Disrupted tight junctions in the small intestine of cystic fibrosis mice","volume":"355","author":"De Lisle","year":"2014","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.isci.2024.111153_bib280","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jcf.2024.02.015","article-title":"Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6\u00a0months of elexacaftor\/tezacaftor\/ivacaftor","volume":"23","author":"Duong","year":"2024","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib281","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1183\/09031936.00183409","article-title":"Critical role of cytosolic phospholipase A2{alpha} in bronchial mucus hypersecretion in CFTR-deficient mice","volume":"36","author":"Dif","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.isci.2024.111153_bib282","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev.physiol.62.1.467","article-title":"Role of CFTR in the colon","volume":"62","author":"Greger","year":"2000","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib283","first-page":"341-e387","article-title":"Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine","volume":"22","author":"de Lisle","year":"2010","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.isci.2024.111153_bib284","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198457","article-title":"Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis","volume":"13","author":"de Freitas","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.111153_bib285","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3389\/fmicb.2018.02147","article-title":"Diet, Microbiota and Gut-Lung Connection","volume":"9","author":"Anand","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2024.111153_bib286","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fmicb.2020.00301","article-title":"The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2024.111153_bib287","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1053\/jhep.2000.9111","article-title":"Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis","volume":"32","author":"Kinnman","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.111153_bib288","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/0016-5085(93)91085-V","article-title":"Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells","volume":"105","author":"Cohn","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2024.111153_bib289","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3390\/membranes11110804","article-title":"The Distribution and Role of the CFTR Protein in the Intracellular Compartments","volume":"11","author":"Lukasiak","year":"2021","journal-title":"Membranes"},{"key":"10.1016\/j.isci.2024.111153_bib290","first-page":"357","article-title":"The pathological changes in the liver in cystic fibrosis of the pancreas","volume":"93","author":"Craig","year":"1957","journal-title":"AMA J. Dis. Child."},{"key":"10.1016\/j.isci.2024.111153_bib291","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.510300527","article-title":"Natural history of liver disease in cystic fibrosis","volume":"30","author":"Lindblad","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.111153_bib292","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MPG.0b013e318249438c","article-title":"Long-chain PUFA in granulocytes, mononuclear cells, and RBC in patients with cystic fibrosis: relation to liver disease","volume":"55","author":"J\u00f8rgensen","year":"2012","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib293","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0676.1994.tb00004.x","article-title":"Liver function and morphology during long-term fatty acid supplementation in cystic fibrosis","volume":"14","author":"Strandvik","year":"1994","journal-title":"Liver"},{"key":"10.1016\/j.isci.2024.111153_bib294","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.111153_bib295","first-page":"131","article-title":"Care of patients with cystic fibrosis. Treatment, screening and clinical outcome","volume":"64","author":"Strandvik","year":"2006","journal-title":"Ann. Nestl\u00e9"},{"key":"10.1016\/j.isci.2024.111153_bib296","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jcf.2021.03.014","article-title":"Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study","volume":"21","author":"Colombo","year":"2022","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib297","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.24183","article-title":"Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease","volume":"53","author":"Witters","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.111153_bib298","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jcf.2017.03.006","article-title":"Liver disease in cystic fibrosis presents as non-cirrhotic portal hypertension","volume":"16","author":"Witters","year":"2017","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib299","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00000542-200506000-00028","article-title":"Endothelium-derived hyperpolarizing factor: a cousin to nitric oxide and prostacyclin","volume":"102","author":"Bryan","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.isci.2024.111153_bib300","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11010-021-04260-9","article-title":"Modulation of endothelium function by fatty acids","volume":"477","author":"Mallick","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.isci.2024.111153_bib301","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/bioengineering10010117","article-title":"Significance of Pulmonary Endothelial Injury and the Role of Cyclooxygenase-2 and Prostanoid Signaling","volume":"10","author":"Nickl","year":"2023","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.isci.2024.111153_bib302","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/00365528809090231","article-title":"Sclerosing cholangitis in cystic fibrosis","volume":"143","author":"Strandvik","year":"1988","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"10.1016\/j.isci.2024.111153_bib303","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0168-8278(99)80259-1","article-title":"Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study","volume":"30","author":"Durieu","year":"1999","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.isci.2024.111153_bib304","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.1840160215","article-title":"Bile-duct destruction and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis","volume":"16","author":"Lindblad","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.111153_bib305","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.1840060513","article-title":"Morphological findings in the liver of children with cystic fibrosis: a light and electron microscopical study","volume":"6","author":"Hultcrantz","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.111153_bib306","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00439-003-0963-z","article-title":"Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis","volume":"113","author":"Sheth","year":"2003","journal-title":"Hum. Genet."},{"key":"10.1016\/j.isci.2024.111153_bib307","first-page":"90","article-title":"Gastrointestinal malignancy in cystic fibrosis","volume":"35","author":"Hough","year":"2020","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.isci.2024.111153_bib308","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199502233320803","article-title":"The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group","volume":"332","author":"Neglia","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.111153_bib309","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/00365518009091970","article-title":"Excretion of bile acids in healthy children and children with cystic fibrosis","volume":"40","author":"Eklund","year":"1980","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.isci.2024.111153_bib310","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jcf.2018.08.009","article-title":"Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosis","volume":"18","author":"van de Peppel","year":"2019","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib311","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(96)80326-6","article-title":"Bile acid kinetics and biliary lipid composition in cystic fibrosis","volume":"25","author":"Strandvik","year":"1996","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.isci.2024.111153_bib312","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/00365528009181435","article-title":"Urinary bile acid excretion in correlation to liver histopathology in cystic fibrosis","volume":"15","author":"Arborgh","year":"1980","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.isci.2024.111153_bib313","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/00365528509091668","article-title":"Fasting serum bile acid levels in relation to liver histopathology in cystic fibrosis","volume":"20","author":"Strandvik","year":"1985","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.isci.2024.111153_bib314","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.dld.2021.06.034","article-title":"Serum bile acids in cystic fibrosis patients - glycodeoxycholic acid as a potential marker of liver disease","volume":"54","author":"Drzyma\u0142a-Czy\u017c","year":"2022","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.isci.2024.111153_bib315","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12967-019-02139-4","article-title":"Renal involvement and metabolic alterations in adults patients affected by cystic fibrosis","volume":"17","author":"Lai","year":"2019","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.isci.2024.111153_bib316","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0140-6736(82)91842-6","article-title":"Renal disturbance in cystic fibrosis","volume":"1","author":"Strandvik","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2024.111153_bib317","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1651-2227.1982.tb09528.x","article-title":"Renal function in cystic fibrosis with special reference to the renal sodium handling","volume":"71","author":"Berg","year":"1982","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.isci.2024.111153_bib318","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0022-3476(89)80072-1","article-title":"Effect on renal function of essential fatty acid supplementation in cystic fibrosis","volume":"115","author":"Strandvik","year":"1989","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.isci.2024.111153_bib319","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jand.2020.05.011","article-title":"Sodium Status and Replacement in Children and Adults Living with Cystic Fibrosis: A Narrative Review","volume":"120","author":"Declercq","year":"2020","journal-title":"J.\u00a0Acad. Nutr. Diet."},{"key":"10.1016\/j.isci.2024.111153_bib320","first-page":"36","article-title":"Total exchangable sodium in cystic fibrosis","volume":"14","author":"Strandvik","year":"1981","journal-title":"Monogr. Paediatr."},{"key":"10.1016\/j.isci.2024.111153_bib321","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jcf.2015.12.010","article-title":"Low sodium status in cystic fibrosis-as assessed by calculating fractional Na(+) excretion-is associated with decreased growth parameters","volume":"15","author":"Knepper","year":"2016","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib322","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.coph.2013.11.010","article-title":"Epithelial sodium channel (ENaC) and the control of blood pressure","volume":"15","author":"Rossier","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.isci.2024.111153_bib323","doi-asserted-by":"crossref","first-page":"37402","DOI":"10.1074\/jbc.M704084200","article-title":"The epithelial sodium channel (ENaC) traffics to apical membrane in lipid rafts in mouse cortical collecting duct cells","volume":"282","author":"Hill","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.111153_bib324","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.3390\/ijms22052739","article-title":"Is the ENaC Dysregulation in CF an Effect of Protein-Lipid Interaction in the Membranes?","volume":"22","author":"Strandvik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.111153_bib325","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1681\/ASN.2008020225","article-title":"Mechanisms of ENaC regulation and clinical implications","volume":"19","author":"Bhalla","year":"2008","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2024.111153_bib326","doi-asserted-by":"crossref","first-page":"F1610","DOI":"10.1152\/ajprenal.00283.2012","article-title":"Liver X receptor agonists decrease ENaC-mediated sodium transport in collecting duct cells","volume":"303","author":"Soodvilai","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib327","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/psp4.12832","article-title":"Altered intravenous drug disposition in people living with cystic fibrosis: A meta-analysis integrating top-down and bottom-up data","volume":"11","author":"De Sutter","year":"2022","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.isci.2024.111153_bib328","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1651-2227.1991.tb11833.x","article-title":"Decreased renal clearance of sodium in cystic fibrosis","volume":"80","author":"Stenvinkel","year":"1991","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.isci.2024.111153_bib329","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/17425255.2021.1836157","article-title":"The pharmacokinetics of antibiotics in cystic fibrosis","volume":"17","author":"Akkerman-Nijland","year":"2021","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.isci.2024.111153_bib330","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/clpt.1988.177","article-title":"Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis","volume":"44","author":"Alv\u00e1n","year":"1988","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.isci.2024.111153_bib331","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2165\/00003088-199018020-00006","article-title":"Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis","volume":"18","author":"Hedman","year":"1990","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.isci.2024.111153_bib332","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1042\/cs0790299","article-title":"Renal function in rats with essential fatty acid deficiency","volume":"79","author":"Hjelte","year":"1990","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.isci.2024.111153_bib333","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3945\/jn.113.177360","article-title":"Dietary linoleic acid and \u03b1-linolenic acid differentially affect renal oxylipins and phospholipid fatty acids in diet-induced obese rats","volume":"143","author":"Caligiuri","year":"2013","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib334","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1194\/jlr.M078097","article-title":"Dietary LA and sex effects on oxylipin profiles in rat kidney, liver, and serum differ from their effects on PUFAs","volume":"58","author":"Leng","year":"2017","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.isci.2024.111153_bib335","first-page":"G116","article-title":"Absorption and metabolism of [3H]arachidonic and [14C]linoleic acid in essential fatty acid-deficient rats","volume":"259","author":"Hjelte","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib336","doi-asserted-by":"crossref","first-page":"15736","DOI":"10.1016\/S0021-9258(17)36320-2","article-title":"Paradoxical conservation of cardiac and renal arachidonate content in essential fatty acid deficiency","volume":"260","author":"Lefkowith","year":"1985","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.111153_bib337","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00232-008-9145-1","article-title":"Effects of lipids on ENaC activity in cultured mouse cortical collecting duct cells","volume":"227","author":"Wang","year":"2009","journal-title":"J.\u00a0Membr. Biol."},{"key":"10.1016\/j.isci.2024.111153_bib338","doi-asserted-by":"crossref","first-page":"L445","DOI":"10.1152\/ajplung.00419.2001","article-title":"Primary inflammation in human cystic fibrosis small airways","volume":"283","author":"Tirouvanziam","year":"2002","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib339","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ppul.1950200203","article-title":"The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis","volume":"20","author":"Balough","year":"1995","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.isci.2024.111153_bib340","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1165\/rcmb.2014-0250OC","article-title":"Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs","volume":"52","author":"Keiser","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.isci.2024.111153_bib341","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/00365518609083706","article-title":"Increased mole fraction of arachidonic acid in bronchial phospholipids in patients with cystic fibrosis","volume":"46","author":"Gilljam","year":"1986","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.isci.2024.111153_bib342","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1073\/pnas.83.23.9202","article-title":"Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect","volume":"83","author":"Carlstedt-Duke","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.111153_bib343","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1378\/chest.06-2635","article-title":"Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic function, Pseudomonas infection, and polyunsaturated fatty acids","volume":"131","author":"Keen","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.isci.2024.111153_bib344","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/MPG.0b013e3181b47967","article-title":"Supplementation with fatty acids influences the airway nitric oxide and inflammatory markers in patients with cystic fibrosis","volume":"50","author":"Keen","year":"2010","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib345","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jcf.2012.09.004","article-title":"Lung transplantation in cystic fibrosis normalizes essential fatty acid profiles","volume":"12","author":"Witters","year":"2013","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib346","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1542\/peds.64.2.207","article-title":"Intravenous linoleic acid supplementation in children with cystic fibrosis","volume":"64","author":"Chase","year":"1979","journal-title":"Pediatrics"},{"key":"10.1016\/j.isci.2024.111153_bib347","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ajcn\/44.6.816","article-title":"The essential fatty acid deficient chicken as a model for cystic fibrosis","volume":"44","author":"Craig-Schmidt","year":"1986","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib348","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcf.2008.11.001","article-title":"Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden","volume":"8","author":"Knudsen","year":"2009","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib349","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1111\/apa.15880","article-title":"Maintaining normal lung function in children with cystic fibrosis is possible with aggressive treatment regardless of Pseudomonas aeruginosa infections","volume":"110","author":"Hansen","year":"2021","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.isci.2024.111153_bib350","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.3390\/ijms23147750","article-title":"Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis","volume":"23","author":"Jaganathan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.111153_bib351","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jcf.2020.11.010","article-title":"Prostaglandin E(2) and phagocytosis of inhaled particulate matter by airway macrophages in cystic fibrosis","volume":"20","author":"Liu","year":"2021","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib352","doi-asserted-by":"crossref","first-page":"2102861","DOI":"10.1183\/13993003.02861-2021","article-title":"Cystic fibrosis macrophage function and clinical outcomes after elexacaftor\/tezacaftor\/ivacaftor","volume":"61","author":"Zhang","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.isci.2024.111153_bib353","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-009-9316-9","article-title":"The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis","volume":"86","author":"Paccou","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.isci.2024.111153_bib354","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1651-2227.2003.tb00601.x","article-title":"Decreased bone mineral density in normal-growing patients with cystic fibrosis","volume":"92","author":"Gronowitz","year":"2003","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.isci.2024.111153_bib355","first-page":"98","article-title":"Nutrition in Cystic Fibrosis","volume":"3","author":"Garemo","year":"1999","journal-title":"Scand. J. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib356","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1542\/peds.114.2.435","article-title":"Normal annual increase of bone mineral density during two years in patients with cystic fibrosis","volume":"114","author":"Gronowitz","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.isci.2024.111153_bib357","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1079\/BJN20061778","article-title":"Serum phospholipid fatty acid pattern is associated with bone mineral density in children, but not adults, with cystic fibrosis","volume":"95","author":"Gronowitz","year":"2006","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib358","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1017\/S000711450780105X","article-title":"Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis","volume":"99","author":"Gronowitz","year":"2008","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib359","first-page":"172","article-title":"Bone metabolism in children and adolescents: main characteristics of the determinants of peak bone mass","volume":"10","author":"Stagi","year":"2013","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"10.1016\/j.isci.2024.111153_bib360","doi-asserted-by":"crossref","first-page":"14203","DOI":"10.3390\/molecules181114203","article-title":"Investigating the role of polyunsaturated fatty acids in bone development using animal models","volume":"18","author":"Lau","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2024.111153_bib361","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0952-3278(03)00063-2","article-title":"Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism","volume":"68","author":"Watkins","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib362","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.plipres.2015.03.001","article-title":"Pros and cons of fatty acids in bone biology","volume":"58","author":"Wauquier","year":"2015","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.isci.2024.111153_bib363","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0163-7827(00)00016-3","article-title":"Bioactive fatty acids: role in bone biology and bone cell function","volume":"40","author":"Watkins","year":"2001","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.isci.2024.111153_bib364","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/03008209509010823","article-title":"The role of prostaglandins in bone formation","volume":"31","author":"Harada","year":"1995","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.isci.2024.111153_bib365","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2023.102606","article-title":"Serum phospholipid fatty acids are associated with bone mass in healthy 4-years-old children","volume":"200","author":"Garemo","year":"2024","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib366","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1017\/S0007114508190286","article-title":"Fatty acid pattern in serum is associated with bone mineralisation in healthy 8-year-old children","volume":"102","author":"Eriksson","year":"2009","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib367","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000406.pub4","article-title":"Oral calorie supplements for cystic fibrosis","author":"Smyth","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.isci.2024.111153_bib368","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1203\/PDR.0b013e3181b4e8d3","article-title":"Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy","volume":"66","author":"Ald\u00e1miz-Echevarr\u00eda","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.isci.2024.111153_bib369","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1651-2227.1996.tb13947.x","article-title":"Essential fatty acid deficiency and predisposition to lung disease in cystic fibrosis","volume":"85","author":"Lloyd-Still","year":"1996","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.isci.2024.111153_bib370","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-277X.2003.00451.x","article-title":"Five-year prospective analysis of dietary intake and clinical status in malnourished cystic fibrosis patients","volume":"16","author":"Walkowiak","year":"2003","journal-title":"J.\u00a0Hum. Nutr. Diet."},{"key":"10.1016\/j.isci.2024.111153_bib371","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jand.2020.01.007","article-title":"Antioxidant Micronutrients and Essential Fatty Acids Supplementation on Cystic Fibrosis Outcomes: A Systematic Review","volume":"120","author":"Simon","year":"2020","journal-title":"J.\u00a0Acad. Nutr. Diet."},{"key":"10.1016\/j.isci.2024.111153_bib372","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clnu.2023.12.017","article-title":"ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis","volume":"43","author":"Wilschanski","year":"2024","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib373","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3945\/ajcn.2009.28206","article-title":"Linoleic acid is associated with lower long-chain n-6 and n-3 fatty acids in red blood cell lipids of Canadian pregnant women","volume":"91","author":"Friesen","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib374","doi-asserted-by":"crossref","first-page":"L599","DOI":"10.1152\/ajplung.00346.2009","article-title":"Linoleic acid supplementation results in increased arachidonic acid and eicosanoid production in CF airway cells and in cftr-\/- transgenic mice","volume":"299","author":"Zaman","year":"2010","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib375","doi-asserted-by":"crossref","first-page":"L597","DOI":"10.1152\/ajplung.00257.2010","article-title":"Linoleic acid supplement in cystic fibrosis: friend or foe?","volume":"299","author":"Vij","year":"2010","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib376","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/adc.61.4.362","article-title":"Physical activity and self treatment in cystic fibrosis","volume":"61","author":"Blomquist","year":"1986","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.isci.2024.111153_bib377","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1651-2227.1992.tb12239.x","article-title":"Home intravenous antibiotic treatment of patients with cystic fibrosis","volume":"81","author":"Strandvik","year":"1992","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.isci.2024.111153_bib378","first-page":"146s","article-title":"Antibiotic therapy of pulmonary infections in cystic fibrosis. Dosage schedules and duration of treatment","volume":"94","author":"Strandvik","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.isci.2024.111153_bib379","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002201.pub3","article-title":"Omega-3 fatty acids for cystic fibrosis","author":"Oliver","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.isci.2024.111153_bib380","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.plefa.2007.12.005","article-title":"Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients","volume":"78","author":"Van Biervliet","year":"2008","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib381","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.plefa.2012.10.002","article-title":"A randomized placebo-controlled study on high-dose oral algal docosahexaenoic acid supplementation in children with cystic fibrosis","volume":"88","author":"Alicandro","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib382","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102186","article-title":"Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial","volume":"162","author":"L\u00f3pez-Neyra","year":"2020","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib383","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1194\/jlr.P013722","article-title":"Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients","volume":"52","author":"Ollero","year":"2011","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.isci.2024.111153_bib384","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171249","article-title":"Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis","volume":"12","author":"Eickmeier","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.111153_bib385","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jcf.2006.12.005","article-title":"Fatty acids platelets and oxidative markers following intravenous n-3 fatty acids administration in cystic fibrosis: An open pilot observational study","volume":"6","author":"Durieu","year":"2007","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2024.111153_bib386","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.arbres.2009.11.001","article-title":"Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis","volume":"46","author":"Olveira","year":"2010","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.isci.2024.111153_bib387","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101165","article-title":"Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions","volume":"86","author":"Dyall","year":"2022","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.isci.2024.111153_bib388","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1165\/rcmb.2014-0223OC","article-title":"Proresolving Action of Docosahexaenoic Acid Monoglyceride in Lung Inflammatory Models Related to Cystic Fibrosis","volume":"53","author":"Morin","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.isci.2024.111153_bib389","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/jc.2005-1303","article-title":"Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers","volume":"91","author":"Ferrucci","year":"2006","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.111153_bib390","doi-asserted-by":"crossref","first-page":"G818","DOI":"10.1152\/ajpgi.00106.2013","article-title":"Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory proresolving lipid mediators","volume":"305","author":"Kalish","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib391","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1194\/jlr.M800035-JLR200","article-title":"A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA","volume":"49","author":"Al-Turkmani","year":"2008","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.isci.2024.111153_bib392","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.plefa.2016.08.011","article-title":"Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study","volume":"113","author":"O'Connor","year":"2016","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib393","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s42003-020-0909-1","article-title":"The bidirectional relationship between CFTR and lipids","volume":"3","author":"Cottrill","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.isci.2024.111153_bib394","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1073\/pnas.87.18.7334","article-title":"Fatty acids inhibit apical membrane chloride channels in airway epithelia","volume":"87","author":"Anderson","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.111153_bib395","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1139\/y00-014","article-title":"Inhibition of cystic fibrosis transmembrane conductance regulator chloride channel currents by arachidonic acid","volume":"78","author":"Linsdell","year":"2000","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.isci.2024.111153_bib396","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2007.02.048","article-title":"Molecular mechanism of arachidonic acid inhibition of the CFTR chloride channel","volume":"563","author":"Zhou","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.isci.2024.111153_bib397","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.bbamem.2017.04.012","article-title":"Lipids as central modulators of sensory TRP channels","volume":"1859","author":"Ciardo","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.isci.2024.111153_bib398","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1096\/fj.05-4683fje","article-title":"Docosahexaenoic acid selectively inhibits plasma membrane targeting of lipidated proteins","volume":"20","author":"Seo","year":"2006","journal-title":"Faseb. J."},{"key":"10.1016\/j.isci.2024.111153_bib399","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nature13419","article-title":"Membrane proteins bind lipids selectively to modulate their structure and function","volume":"510","author":"Laganowsky","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.111153_bib400","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bbagen.2014.05.010","article-title":"Structural insights into functional lipid-protein interactions in secondary transporters","volume":"1850","author":"Koshy","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.isci.2024.111153_bib401","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1021\/ja3119114","article-title":"Structural determinants of specific lipid binding to potassium channels","volume":"135","author":"Weingarth","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.isci.2024.111153_bib402","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(03)00056-7","article-title":"Lipid-protein interactions in biological membranes: a structural perspective","volume":"1612","author":"Lee","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.isci.2024.111153_bib403","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1021\/bi00803a003","article-title":"Phospholipid class and fatty acid composition of golgi apparatus isolated from rat liver and comparison with other cell fractions","volume":"9","author":"Keenan","year":"1970","journal-title":"Biochemistry"},{"key":"10.1016\/j.isci.2024.111153_bib404","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/jcb.22652","article-title":"Long chain-polyunsaturated fatty acids modulate membrane phospholipid composition and protein localization in lipid rafts of neural stem cell cultures","volume":"110","author":"Langelier","year":"2010","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.isci.2024.111153_bib405","doi-asserted-by":"crossref","first-page":"11161","DOI":"10.1021\/bi020289s","article-title":"Role for phospholipid interactions in the trafficking defect of Delta F508-CFTR","volume":"41","author":"Eidelman","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.isci.2024.111153_bib406","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbamem.2016.11.013","article-title":"Specific stabilization of CFTR by phosphatidylserine","volume":"1859","author":"Hildebrandt","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.isci.2024.111153_bib407","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365528809090205","article-title":"Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis","volume":"143","author":"Strandvik","year":"1988","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"10.1016\/j.isci.2024.111153_bib408","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/dna.1997.16.749","article-title":"Cystic fibrosis gene mutation (deltaF508) is associated with an intrinsic abnormality in Ca2+-induced arachidonic acid release by epithelial cells","volume":"16","author":"Miele","year":"1997","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.isci.2024.111153_bib409","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0925-4439(93)90026-W","article-title":"Increase of bradykinin-stimulated arachidonic acid release in a delta F508 cystic fibrosis epithelial cell line","volume":"1181","author":"Levistre","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.isci.2024.111153_bib410","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1165\/ajrcmb.17.4.2734","article-title":"Differential stimulation of cytosolic phospholipase A2 by bradykinin in human cystic fibrosis cell lines","volume":"17","author":"Berguerand","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.isci.2024.111153_bib411","doi-asserted-by":"crossref","first-page":"16083","DOI":"10.3390\/ijms150916083","article-title":"Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications","volume":"15","author":"Seegmiller","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.111153_bib412","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1194\/jlr.M050369","article-title":"Abnormal n-6 fatty acid metabolism in cystic fibrosis is caused by activation of AMP-activated protein kinase","volume":"55","author":"Umunakwe","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.isci.2024.111153_bib413","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.3390\/ijms19113495","article-title":"AMP-Activated Protein Kinase and Host Defense against Infection","volume":"19","author":"Silwal","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.111153_bib414","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1074\/mcp.M500019-MCP200","article-title":"Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients","volume":"4","author":"Bensalem","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.isci.2024.111153_bib415","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1042\/bj20021856","article-title":"Attenuation of glucocorticoid functions in an Anx-A1-\/- cell line","volume":"371","author":"Croxtall","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.isci.2024.111153_bib416","first-page":"541","article-title":"The annexin-1 knockout mouse: what it tells us about the inflammatory response","volume":"53","author":"Roviezzo","year":"2002","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.isci.2024.111153_bib417","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/sj.bjp.0705858","article-title":"Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophages","volume":"142","author":"Yona","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.isci.2024.111153_bib418","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.plefa.2004.10.008","article-title":"Macrophage biology in the Anx-A1-\/- mouse","volume":"72","author":"Yona","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.isci.2024.111153_bib419","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1534-5807(03)00090-X","article-title":"Annexin I is an endogenous ligand that mediates apoptotic cell engulfment","volume":"4","author":"Arur","year":"2003","journal-title":"Dev. Cell"},{"key":"10.1016\/j.isci.2024.111153_bib420","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1080\/21655979.2022.2031769","volume":"13","author":"Yu","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.isci.2024.111153_bib421","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cellsig.2008.01.021","article-title":"Defective formation of PKA\/CnA-dependent annexin 2-S100A10\/CFTR complex in DeltaF508 cystic fibrosis cells","volume":"20","author":"Borthwick","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.isci.2024.111153_bib422","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/excr.1998.4382","article-title":"The fatty acid-binding heterocomplex FA-p34 formed by S100A8 and S100A9 is the major fatty acid carrier in neutrophils and translocates from the cytosol to the membrane upon stimulation","volume":"247","author":"Roulin","year":"1999","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.isci.2024.111153_bib423","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1465-9921-7-51","article-title":"Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator","volume":"7","author":"Tirkos","year":"2006","journal-title":"Respir. Res."},{"key":"10.1016\/j.isci.2024.111153_bib424","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1189\/jlb.0405206","article-title":"Annexin 1-deficient neutrophils exhibit enhanced transmigration in\u00a0vivo and increased responsiveness in\u00a0vitro","volume":"78","author":"Chatterjee","year":"2005","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.isci.2024.111153_bib425","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4267\/10608\/4270","article-title":"Une homologie frappante entre le CFTR et les annexines","volume":"7","author":"Chap","year":"1991","journal-title":"Medicine\/Science"},{"key":"10.1016\/j.isci.2024.111153_bib426","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3390\/ph17091185","article-title":"Dysregulation of the Arachidonic Acid Pathway in Cystic Fibrosis: Implications for Chronic Inflammation and Disease Progression","volume":"17","author":"D'Orazio","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.isci.2024.111153_bib427","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1165\/2009-0147OC","article-title":"AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells","volume":"42","author":"Myerburg","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.isci.2024.111153_bib428","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1074\/jbc.M511029200","article-title":"Up-regulation of AMP-activated kinase by dysfunctional cystic fibrosis transmembrane conductance regulator in cystic fibrosis airway epithelial cells mitigates excessive inflammation","volume":"281","author":"Hallows","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.111153_bib429","first-page":"193","article-title":"Control of epithelial Na+ conductance by the cystic fibrosis transmembrane conductance regulator","volume":"440","author":"Kunzelmann","year":"2000","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.isci.2024.111153_bib430","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1113\/jphysiol.2004.079046","article-title":"CFTR fails to inhibit the epithelial sodium channel ENaC expressed in Xenopus laevis oocytes","volume":"564","author":"Nagel","year":"2005","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib431","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1039\/B810471A","article-title":"Assessment of the CFTR and ENaC association","volume":"5","author":"Berdiev","year":"2009","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.isci.2024.111153_bib432","doi-asserted-by":"crossref","first-page":"L557","DOI":"10.1152\/ajplung.00094.2011","article-title":"Enhancement of alveolar epithelial sodium channel activity with decreased cystic fibrosis transmembrane conductance regulator expression in mouse lung","volume":"301","author":"Lazrak","year":"2011","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib433","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00418-011-0904-1","article-title":"Epithelial sodium channels (ENaC) are uniformly distributed on motile cilia in the oviduct and the respiratory airways","volume":"137","author":"Enuka","year":"2012","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.isci.2024.111153_bib434","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1681\/ASN.2016020124","article-title":"Coordinated Control of ENaC and Na+,K+-ATPase in Renal Collecting Duct","volume":"27","author":"Feraille","year":"2016","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2024.111153_bib435","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1203\/00006450-199205000-00001","article-title":"Erythrocyte sodium-potassium transport in cystic fibrosis","volume":"31","author":"Sigstr\u00f6m","year":"1992","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.isci.2024.111153_bib436","doi-asserted-by":"crossref","first-page":"2000946","DOI":"10.1183\/13993003.00946-2020","article-title":"ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies","volume":"56","author":"Mall","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.isci.2024.111153_bib437","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/f9b8a9d2-4be3-4981-92f4-a3b4cb0b0bf5","article-title":"CFTR depletion results in changes in fatty acid composition and promotes lipogenesis in intestinal Caco 2\/15 cells","volume":"5","author":"Mailhot","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.111153_bib438","doi-asserted-by":"crossref","first-page":"F583","DOI":"10.1152\/ajprenal.00579.2012","article-title":"Activation of liver X receptors reduces CFTR-mediated Cl(-) transport in kidney collecting duct cells","volume":"305","author":"Raksaseri","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.isci.2024.111153_bib439","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm820","article-title":"Reciprocal regulation of inflammation and lipid metabolism by liver X receptors","volume":"9","author":"Joseph","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.isci.2024.111153_bib440","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cell.2008.04.052","article-title":"LXR signaling couples sterol metabolism to proliferation in the acquired immune response","volume":"134","author":"Bensinger","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.isci.2024.111153_bib441","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.gde.2008.07.016","article-title":"Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors","volume":"18","author":"Hong","year":"2008","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.isci.2024.111153_bib442","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1097-2765(03)00384-8","article-title":"Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism","volume":"12","author":"Castrillo","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2024.111153_bib443","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/ATVBAHA.112.300812","article-title":"Liver x receptor regulates arachidonic acid distribution and eicosanoid release in human macrophages: a key role for lysophosphatidylcholine acyltransferase 3","volume":"33","author":"Ishibashi","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.isci.2024.111153_bib444","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.nutr.25.051804.101917","article-title":"Polyunsaturated fatty acid regulation of genes of lipid metabolism","volume":"25","author":"Sampath","year":"2005","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.isci.2024.111153_bib445","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","article-title":"From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations","volume":"27","author":"Veit","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.isci.2024.111153_bib446","doi-asserted-by":"crossref","first-page":"e148841","DOI":"10.1172\/jci.insight.148841","article-title":"CFTR bearing variant p.Phe312del exhibits function inconsistent with phenotype and negligible response to ivacaftor","volume":"7","author":"Raraigh","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2024.111153_bib447","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.tibs.2011.06.007","article-title":"Biological membranes: the importance of molecular detail","volume":"36","author":"Lee","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.isci.2024.111153_bib448","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.bbamem.2017.05.017","article-title":"Membrane-lipid therapy: A historical perspective of membrane-targeted therapies - From lipid bilayer structure to the pathophysiological regulation of cells","volume":"1859","author":"Escrib\u00e1","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224023782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224023782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T21:03:27Z","timestamp":1783371807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224023782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":448,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2589004224023782"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.111153","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatty acid abnormalities in cystic fibrosis\u2013the missing link for a cure?","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.111153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111153"}}